Changes in the ratio of anti-apoptotic members Bcl-2/MCL-1 also have an important impact on the efficacy of anti-tumor drugs in HCC (Tutusaus et al., 2018). This evidence concerns the gene MCL1 and hepatocellular carcinoma.